Completion of placing to raise £7m to support the rapid development of the Genedrive® SARS-CoV-2 assays, fund the scale-up of the Genedrive-96-SARS-CoV-2 test including build-up of inventory for an initial period, fund product development, commercialisation and general corporate purposes.
Completion of oversubscribed placing to raise £3m to expand the existing proof-of-concept work on the Mammalian Antibody Library to include COVID-19, the existing oncology targets and for general working capital purposes.
Medical Equipment and Services (Medical Equipment)
17 April 2020
Completion of placing, raising £5.2m to complete the initial development work on the next ScanNav products that include liver, prostate and COVID-19 variants, to develop a new neonate simulator and to strengthen the balance sheet and for general working capital purposes.
Completion of placing to raise £5m to increase sales and marketing resources, adding more support to North American based channel partner relationships; improve capacity to reduce time taken to on-board and enable new partners